Startups must focus very tightly on a specific target market and value proposition to have the best chance of avoiding the doom loop of medtech innovation.
The number of funding disclosures in 2020 demonstrates investment interest in orthopedics’ smaller companies and novel technologies even amongst COVID-19s hit on the industry.
CEO Nick Deeter says that 95% of children continue to receive adult orthopedic products that were never intended for them nor cleared by FDA for use in children. WishBone seeks to change the paradigm of pediatric orthopedics with its child-focused implants and sterile packaged disposable kits.
Eeric Truumees, M.D., First Vice President of NASS’ Board of Directors, is optimistic that the online virtual annual meeting event in October will allow attendees to benefit from broader input in smaller doses.